Comparison of Progression Rate of Retinal Pigment Epithelium Loss in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Aflibercept

Purpose. Retinal pigment epithelium (RPE) loss in neovascular age-related macular degeneration (nAMD) seem to have a linear progression but might be influenced by the treatment. The purpose of the study is the comparison of RPE loss over three years in patients treated with intravitreal ranibizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Wons, Juliana, Wirth, Magdalena A., Graf, Nicole, Becker, Matthias D., Michels, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338067/
https://www.ncbi.nlm.nih.gov/pubmed/28316836
http://dx.doi.org/10.1155/2017/7432739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338067/
https://www.ncbi.nlm.nih.gov/pubmed/28316836
http://dx.doi.org/10.1155/2017/7432739

Ejemplares similares